(Q42464328)

1 November 2017

Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

1 November 2017

1 reference

3

1 reference

1 November 2017

9

Antje Prasse

0 references

Prescott G. Woodruff

1

object named as

Prescott G Woodruff

1 reference

1 November 2017

13

John V Fahy

1 reference

1 November 2017

12

Ralf Heilker

1 reference

1 November 2017

Michael Wolff

2

1 reference

1 November 2017

Norbert Krug

4

1 reference

1 November 2017

Mark T Dransfield

5

1 reference

1 November 2017

E Rand Sutherland

6

1 reference

1 November 2017

Gerard J Criner

7

1 reference

1 November 2017

Victor Kim

8

1 reference

1 November 2017

Antje Prasse

9

1 reference

1 November 2017

Michael C Nivens

10

1 reference

1 November 2017

Kay Tetzlaff

11

1 reference

1 November 2017

language of work or name

English

0 references

publication date

10 December 2009

1 reference

American Journal of Respiratory and Critical Care Medicine

1 November 2017

1 reference

1 November 2017

181

1 reference

1 November 2017

5

1 reference

1 November 2017

438-445

1 reference

What predicts change in pulmonary function and quality of life in asthma or COPD?

1 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Airway goblet cells: responsive and adaptable front-line defenders

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

The role of epidermal growth factor in mucus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Targeted therapy for the treatment of advanced non-small cell lung cancer: a review of the epidermal growth factor receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Kinetics of binding, endocytosis, and recycling of EGF receptor mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Effect of tyrosine kinase inhibitors on clathrin-coated pit recruitment and internalization of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Epidermal growth factor system regulates mucin production in airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Role of epidermal growth factor receptor activation in regulating mucin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Overview of the tolerability of gefitinib (IRESSA) monotherapy : clinical experience in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200909-1415OC

10.1164/RCCM.200909-1415OC

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference